-
Leveraging Real World Radiation Medicine Health Data to Drive Evidence-Based Cancer Care Policies: An Insights From the IAEA SUNRISE Project
Sep 18, 2025, 18:38 PM -
Predicting Survival in Multiple Myeloma Patients With Diabetes Using Machine Learning: A 20-Year Cohort Study
Sep 18, 2025, 18:38 PM -
Interventions Promoting the Acceptance and Uptake of Generic Medicines: A Systematic Review
Sep 18, 2025, 18:38 PM -
A Cost-Utility Analysis of Ferric Derisomaltose vs. Ferric Carboxymaltose in Patients with Iron Deficiency Anemia and Inflammatory Bowel Disease in the United Kingdom: Accounting for Difference in Fracture Risk
Sep 9, 2025, 16:22 PM -
Natural History of Creutzfeldt-Jakob Disease: A Comparison of Manual vs. Manual Plus AI-Assisted Approaches in Literature Review
Sep 9, 2025, 16:22 PM -
Exploring Value in Healthcare: Patient Satisfaction in Spain Before and After the Pandemic
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Ribociclib With Endocrine Therapy for Treatment With Premenopausal Women With HR Positive HER2 Negative Early Breast Cancer in the UK
Sep 9, 2025, 16:22 PM -
Real-World Healthcare Resource Utilization and Related Costs Associated With Bladder Cancer in the Brazilian Private Market
Sep 9, 2025, 16:22 PM -
Prognostic Accuracy and Clinical Effectiveness of 68Ga-PSMA-11 PET/CT (ILLUCIX®) Imaging Followed by 177-Lu-PSMA-617 Therapy in Metastatic Castration-Resistant Prostate Cancer: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Assessing the Socioeconomic Value of Ocrelizumab Subcutaneous for Treating Relapsing Multiple Sclerosis in the Evolving Treatment Landscape in the United Kingdom
Sep 9, 2025, 16:22 PM -
Changes in the Epidemiological Indicators of Female Infertility in Europe 1991-2021
Sep 9, 2025, 16:22 PM -
Association Between Objective Response and Overall Survival in BRAF V600e-Mutant Metastatic Colorectal Cancer: An Analysis of the BEACON CRC Trial
Sep 9, 2025, 16:22 PM -
Estimating the Public Health and Economic Impact of Recombinant Zoster Vaccine (RZV) Vaccination for Adults Aged 50 and Older in South Korea
Sep 9, 2025, 16:22 PM -
Artificial Intelligence in Pharmaceutical Payer Decision Making—Assessing Current Use, Strategic Intent, and Infrastructure Readiness
Sep 9, 2025, 16:22 PM -
Unlocking Value Early: Insights Into NICE’s Early Value Assessments and Evidence-Generation Plans for Medical Technologies
Sep 9, 2025, 16:22 PM -
Regulatory Timelines for CMA Medicines In Italy: A Comparative Analysis of Pricing and Reimbursement Procedures
Sep 9, 2025, 16:22 PM -
High All-Cause Hospitalization Among Those With Recurrent ASCVD Event: Evidence From a Large-Scale Real-World Database
Sep 9, 2025, 16:22 PM -
Acceptance of Clinical Studies Conducted in Nonus Settings by the FDA Based on the Analysis of Selected Novel Drug Approvals
Sep 9, 2025, 16:22 PM -
Navigating HTA and Innovation: Oncologists’ Perspectives on Access to Cancer Therapies in Bulgaria
Sep 9, 2025, 16:22 PM -
Real-World Hospital Stays Description and Cost Analysis of Immune Checkpoint Inhibitors (ICIs) Using National PMSI Data in France
Sep 9, 2025, 16:22 PM
